Gongwin Biopharm Holdings Co., Ltd. (6617)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
102. 50
-3
-2.8436%
NT$
- Market Cap
- P/E Ratio
116% Div Yield
2.08M Volume
- Eps
NT$ 105.5
Previous Close Want to track 6617 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gongwin Biopharm Holdings Co., Ltd. (6617) Statistics
Valuation metrics
Market Cap -
Enterprise value 11.05B
Trailing P/E (ttm) -83.02
Forward P/E -
PEG ratio 1.25
Price/Sales (ttm) 304.89
Price/Book (mrq) 4.9
Enterprise Value/Revenue 288.55
Enterprise Value/EBITDA -45.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 485.63K
Average volume (90 days) 381.9K
Price summary
52-Week low 58.3
52-Week high 120
Beta -
50-Day moving average 88.6
200-Day moving average 75.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 253:250
Last split Date 20 Jul 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.71%
Operating margin -5.89%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.9
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 9.19%
Book value per share (mrq) 19.54
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
